Masatomo Ishikawa
Chiba, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Oxytocin system dysfunction in patients with treatment-resistant schizophrenia: Alterations of blood oxytocin levels and effect of a genetic variant of OXTR.
Journal: Journal of psychiatric research
Published: August 04, 2020
A randomized-controlled trial of blonanserin and olanzapine as adjunct to antipsychotics in the treatment of patients with schizophrenia and dopamine supersensitivity psychosis: The ROADS study.
Journal: Asian journal of psychiatry
Published: June 07, 2020
Autistic traits and cognitive profiles of treatment-resistant schizophrenia.
Journal: Schizophrenia research. Cognition
Published: April 14, 2020
Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trial.
Journal: Annals of general psychiatry
Published: July 14, 2016
Effectiveness of blonanserin for patients with drug treatment-resistant schizophrenia and dopamine supersensitivity: A retrospective analysis.
Journal: Asian journal of psychiatry
Published: May 09, 2016
Increased serum levels of serine enantiomers in patients with depression.
Journal: Acta neuropsychiatrica
Published: October 30, 2015
Decreased levels of serum oxytocin in pediatric patients with Attention Deficit/Hyperactivity Disorder.
Journal: Psychiatry research
Published: July 29, 2014
Tipepidine in adolescent patients with depression: a 4 week, open-label, preliminary study.
Journal: Neuropsychiatric disease and treatment
Published: May 17, 2014
Tipepidine in children with attention deficit/hyperactivity disorder: a 4-week, open-label, preliminary study.
Journal: Neuropsychiatric disease and treatment
Published: February 05, 2014
Second-generation antipsychotics and bone turnover in schizophrenia.
Journal: Schizophrenia research
Published: November 19, 2013
A prospective comparative study of risperidone long-acting injectable for treatment-resistant schizophrenia with dopamine supersensitivity psychosis.
Journal: Schizophrenia research
Published: September 24, 2013
Last Updated: 09/26/2026